Scientists test new drug cocktail in fight against aggressive blood cancer
Disease control
Ongoing
This study is testing the safety and early effectiveness of adding a new drug, ADI-PEG 20, to a standard two-drug treatment for acute myeloid leukemia (AML). It will involve about 38 adults with either newly diagnosed high-risk AML or AML that has returned after previous treatmen…
Phase: PHASE1 • Sponsor: Polaris Group • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC